VANGUARD GROUP INC - GRITSTONE ONCOLOGY INC ownership

GRITSTONE ONCOLOGY INC's ticker is GRTS and the CUSIP is 39868T105. A total of 117 filers reported holding GRITSTONE ONCOLOGY INC in Q4 2021. The put-call ratio across all filers is 0.59 and the average weighting 0.3%.

Quarter-by-quarter ownership
VANGUARD GROUP INC ownership history of GRITSTONE ONCOLOGY INC
ValueSharesWeighting
Q3 2023$6,980,133
-11.6%
4,058,217
+0.2%
0.00%
Q2 2023$7,895,554
-22.4%
4,049,002
+10.6%
0.00%
Q1 2023$10,177,299
-7.4%
3,660,899
+14.9%
0.00%
Q4 2022$10,992,756
+37.8%
3,186,306
+2.6%
0.00%
Q3 2022$7,980,000
+12.9%
3,104,976
+6.3%
0.00%
Q2 2022$7,067,000
-37.3%
2,920,284
+6.8%
0.00%
Q1 2022$11,267,000
-67.7%
2,734,707
+0.9%
0.00%
-100.0%
Q4 2021$34,867,000
+64.0%
2,711,270
+37.7%
0.00%0.0%
Q3 2021$21,265,000
+63.6%
1,969,024
+38.3%
0.00%
Q2 2021$12,995,000
+16.4%
1,423,249
+20.2%
0.00%
Q1 2021$11,161,000
+243.2%
1,183,599
+43.4%
0.00%
Q4 2020$3,252,000
+20.0%
825,367
-19.3%
0.00%
Q3 2020$2,711,000
-61.9%
1,023,099
-4.4%
0.00%
Q2 2020$7,109,000
+17.6%
1,070,565
+3.1%
0.00%
Q1 2020$6,043,000
-35.1%
1,038,284
-0.0%
0.00%
Q4 2019$9,318,000
+3.5%
1,038,799
-0.3%
0.00%
Q3 2019$9,000,000
-16.8%
1,042,288
+7.3%
0.00%
Q2 2019$10,821,000
+145.5%
971,371
+193.1%
0.00%
Q1 2019$4,408,000
-13.5%
331,465
+0.5%
0.00%
Q4 2018$5,097,000
+379.9%
329,909
+342.2%
0.00%
Q3 2018$1,062,00074,6140.00%
Other shareholders
GRITSTONE ONCOLOGY INC shareholders Q4 2021
NameSharesValueWeighting ↓
Versant Venture Management, LLC 3,561,150$6,125,1783.26%
Redmile Group, LLC 8,509,126$14,635,6970.70%
Avidity Partners Management LP 2,733,800$4,702,1360.19%
Frazier Life Sciences Management, L.P. 1,430,878$2,461,1100.16%
Artia Global Partners LP 95,170$163,6920.07%
Worth Venture Partners, LLC 43,772$75,2880.04%
SkyOak Wealth, LLC 60,875$104,7050.03%
Point72 Asset Management, L.P. 5,924,867$10,190,7710.03%
CORNERCAP INVESTMENT COUNSEL INC 76,811$132,1150.02%
Houlihan Financial Resource Group, Ltd. 20,000$380.02%
View complete list of GRITSTONE ONCOLOGY INC shareholders